[Tailor-made medicine and genomic drug discovery in rheumatoid arthritis]

Nihon Rinsho. 2005 Jan:63 Suppl 1:686-90.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / genetics*
  • Arylamine N-Acetyltransferase / genetics
  • Drug Design*
  • Genome, Human
  • Haplotypes
  • Humans
  • Methotrexate / therapeutic use
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Pharmacogenetics*
  • Sulfasalazine / therapeutic use

Substances

  • Antirheumatic Agents
  • Sulfasalazine
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Arylamine N-Acetyltransferase
  • NAT2 protein, human
  • Methotrexate